LRP2 Antibody (545818) [Janelia Fluor® 549]
Novus Biologicals, part of Bio-Techne | Catalog # MAB95781JF549
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Paraffin
Label
Janelia Fluor 549
Antibody Source
Monoclonal Mouse IgG1 Clone # 545818
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived partial recombinant human Megalin/LRP2 protein (amino acids 3510-3964)
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for LRP2 Antibody (545818) [Janelia Fluor® 549]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Megalin/LRP2
Long Name
LDL Receptor-related Protein 2
Alternate Names
DBS, gp330, LRP-2, LRP2
Gene Symbol
LRP2
Additional Megalin/LRP2 Products
Product Documents for LRP2 Antibody (545818) [Janelia Fluor® 549]
Product Specific Notices for LRP2 Antibody (545818) [Janelia Fluor® 549]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...